Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.

Author: Ji Min KIM ¹ ; Sorim CHOUNG ; Kyong Hye JOUNG ; Ju Hee LEE ; Hyun Jin KIM ; Bon Jeong KU
Author Information

1. Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. bonjeong@cnu.ac.kr
Publication Type:Brief Communication
Keywords: Biological assay; Diabetes mellitus, type 2; Receptor, epidermal growth factor
MeSH: Biological Assay; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2*; Epidermal Growth Factor*; Hemoglobin A, Glycosylated; Humans; Insulin; Receptor, Epidermal Growth Factor*
From:Diabetes & Metabolism Journal 2018;42(4):343-347
CountryRepublic of Korea
Language:English
Abstract: We analyzed circulating soluble epidermal growth factor receptor (sEGFR) levels in humans. Serum sEGFR levels were higher in subjects with newly diagnosed type 2 diabetes mellitus compared with controls. Serum sEGFR was positively correlated with glycosylated hemoglobin and serum glucose and negatively correlated with serum insulin and C-peptide levels.